Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial-Reference-Cited by-同舟云学术

Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial

Published:2018-11-26 Issue:2 Volume:59 Page:201-207
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Statland Jeffrey M.¹^ORCID,Moore Dan²,Wang Yunxia¹,Walsh Maureen¹,Mozaffar Tahseen³,Elman Lauren⁴,Nations Sharon P.⁵,Mitsumoto Hiroshi⁶,Fernandes J. Americo⁷,Saperstein David⁸,Hayat Ghazala⁹,Herbelin Laura¹,Karam Chafic¹⁰,Katz Jonathan²,Wilkins Heather M.¹,Agbas Abdulbaki¹¹,Swerdlow Russell H.¹,Santella Regina M.⁶,Dimachkie Mazen M.¹,Barohn Richard J.¹,

Affiliation:

1. Department of Neurology; University of Kansas Medical Center; 3901 Rainbow Boulevard, MS 2012, Kansas City Kansas, 66160 USA

2. The Forbes Norris MDA/ALS Research Center; California Pacific Medical Center; San Francisco California USA

3. Department of Neurology; University of California, Irvine; Irvine California USA

4. Department of Neurology; University of Pennsylvania; Philadelphia Pennslyvania USA

5. Department of Neurology; University of Texas Southwestern Medical Center; Dallas Texas USA

6. Department of Neurology; Columbia University; New York New York USA

7. Department of Neurology; University of Nebraska Medical Center; Omaha Nebraska USA

8. Phoenix Neurological Associates; Phoenix Arizona USA

9. Department of Neurology; St. Louis University; St. Louis Missouri USA

10. Department of Neurology; Oregon Health and Science University; Portland Oregon USA

11. Department of Biosciences; Kansas City University of Medicine and Bioscience; Kansas City Missouri USA

Funder

U.S. Food and Drug Administration Orphan Products Division

NCATS

CTSA

Columbia's Biomarkers Laboratory

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.26335/fullpdf

Reference49 articles.

1. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs;Goyal;Exp Opin Invest Drugs,2014

2. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial;Edaravone ALSSG Writing Group;Lancet Neurol,2017

3. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group;Bensimon;N Engl J Med,1994

4. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II;Lacomblez;Lancet,1996

5. A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS;Gordon;Amyotroph Lateral Scler,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

2. Cortical hyperexcitability in mouse models and patients with amyotrophic lateral sclerosis is linked to noradrenaline deficiency;Science Translational Medicine;2024-03-13

3. Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data;Orphanet Journal of Rare Diseases;2024-02-02

4. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis;Cells;2024-01-29

5. Vaskuläre Erkrankungen im Bauchraum;Therapie-Handbuch - Gastroenterologie und Hepatologie;2024